The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global optical coherence tomography market was valued at US$ 1.41 Billion in 2021.
We expect the global optical coherence tomography market to exhibit a CAGR of 13.40% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective detection and diagnosis of retinal diseases to reduce the risk of the coronavirus infection upon medical equipment, thereby negatively impacting the global market for optical coherence tomography technique.
The rising incidences of retinal and choroidal disorders, along with the introduction of advanced devices which assist to enhance accuracy as well as improve the overall quality of eye care, are primarily driving the global optical coherence tomography market.
Based on the type, the global optical coherence tomography market has been segmented into handheld OCT devices, tabletop OCT devices, and others. Currently, handheld OCT devices hold the majority of the total market share.
Based on the application, the global optical coherence tomography market can be divided into dermatology, ophthalmology, cardiovascular, oncology, and others. Among these, ophthalmology exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global optical coherence tomography market include Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc., and Topcon Corporation.
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at